Genedx Holdings Corp Stock Today
| WGS Stock | 95.85 0.85 0.89% |
PerformanceModest
| Odds Of DistressLow
|
GeneDx Holdings is selling for under 95.85 as of the 25th of February 2025; that is 0.89% up since the beginning of the trading day. The stock's lowest day price was 87.81. GeneDx Holdings has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 27th of November 2024 and ending today, the 25th of February 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 4th of November 2020 | Category Healthcare | Classification Health Care |
GeneDx Holdings is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 28.07 M outstanding shares of which 2.14 M shares are at this time shorted by investors with about 2.54 days to cover. More on GeneDx Holdings Corp
Moving against GeneDx Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
GeneDx Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Katherine Stueland | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Healthcare (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Healthcare, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsGeneDx Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand GeneDx Holdings' financial leverage. It provides some insight into what part of GeneDx Holdings' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GeneDx Holdings Corp (WGS) is traded on NASDAQ Exchange in USA. It is located in North Tower, Stamford, CT, United States, 06902 and employs 1,000 people. GeneDx Holdings is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 2.67 B. GeneDx Holdings Corp runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 28.07 M outstanding shares of which 2.14 M shares are at this time shorted by investors with about 2.54 days to cover.
GeneDx Holdings generates negative cash flow from operations
Check GeneDx Holdings Probability Of Bankruptcy
Ownership AllocationGeneDx Holdings Corp has a total of 28.07 Million outstanding shares. The majority of GeneDx Holdings Corp outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in GeneDx Holdings to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in GeneDx Holdings Corp. Please pay attention to any change in the institutional holdings of GeneDx Holdings Corp as this could imply that something significant has changed or is about to change at the company. Also note that almost six hundred seventeen thousand five hundred three invesors are currently shorting GeneDx Holdings expressing very little confidence in its future performance.
Check GeneDx Ownership Details
GeneDx Holdings Historical Income Statement
GeneDx Stock Against Markets
GeneDx Holdings Corporate Management
| Daniel JD | Secretary | Profile | |
| Heidi JD | Chief Officer | Profile | |
| Britt Johnson | Head Affairs | Profile | |
| Jami Biliboaca | Head Strategy | Profile | |
| Eric Olivares | Chief Officer | Profile | |
| Tricia Truehart | Head Relations | Profile |
Already Invested in GeneDx Holdings Corp?
The danger of trading GeneDx Holdings Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of GeneDx Holdings is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than GeneDx Holdings. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile GeneDx Holdings Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.